Oncology Institute Inc (TOI)

EBITDA Growth

54.77%

TTM · Period ending:

TOI logo

TOI EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported54.77%
TOI TTM EBITDA YoY % (-127.26% → 54.77%)
High-resolution chart · PNG

TOI ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Oncology Institute Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
54.7684%
37.4079%
16.4367%
10.1699%
10.9625%
16.5815%
6.288%
1.301%
-26.2199%
-65.7821%
-3,739.008%
-1,327.461%
-1,401.2712%
-370.3443%
118.798%
1,146.62%
257.9395%
731.5666%
-102.5087%
-127.2583%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.